Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes

Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes

Abstract Multiple sclerosis (MS) is an inflammatory demyelinating disease with heterogeneous clinical presentations and variable long-term disability accumulation. There are currently no standard criteria to accurately predict disease outcomes. In this study we investigated the cross-sectional relat...

Full description

Bibliographic Details
Main Authors: Alexandra Rabin, Elisa Bello, Saurabh Kumar, Dalia Abou Zeki, Khashayar Afshari, Mugdha Deshpande, Nimmy Francis, Farnaz Khalighinejad, Raffaella Umeton, Irina Radu, Fatima Qutab, Danny Kwong, Mariana Kurban, Christopher Hemond, Jillian M. Richmond, Carolina Ionete
Format: Article
Language:English
Published: Nature Portfolio 2024-09-01
Series:Scientific Reports
Subjects:
Multiple sclerosis (MS)
Targeted proteomics
Cerebrospinal fluid (CSF)
Expanded Disability Status Scale (EDSS)
Age
Online Access:https://doi.org/10.1038/s41598-024-67769-1

Internet

https://doi.org/10.1038/s41598-024-67769-1

Similar Items